SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-320269
Filing Date
2021-11-04
Accepted
2021-11-04 16:49:04
Documents
14
Period of Report
2021-11-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d256630d8k.htm   iXBRL 8-K 24967
2 EX-99.1 d256630dex991.htm EX-99.1 12970
6 GRAPHIC g256630g1104234511719.jpg GRAPHIC 4509
  Complete submission text file 0001193125-21-320269.txt   172073

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20211104.xsd EX-101.SCH 2913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20211104_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20211104_pre.xml EX-101.PRE 11422
7 EXTRACTED XBRL INSTANCE DOCUMENT d256630d8k_htm.xml XML 3415
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 211380705
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences